Most humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responses

Vaccine. 2004 Sep 9;22(27-28):3789-96. doi: 10.1016/j.vaccine.2004.02.046.

Abstract

About 10% of health care professionals vaccinated against hepatitis B virus (HBV) fail to develop protective antibodies. We tested the capacity of peripheral blood lymphocytes from 121 health care professionals, including 76 non-responders, to proliferate to four HBV vaccines, examined the proliferating cells' subset, production of IFN-gamma, IL-4 and IL-10, and for 22 subjects, the cytokine production genotype. Specific proliferative responses to at least one HBV antigen were noted in 75% humoral non-responders. These cells differed from the CD4+ strongly proliferating cells of responders. Non-responders frequently displayed a genotype of high TGF-beta and intermediate IL-10 secretion. Most humoral non-responders to HBV thus develop specific cellular immune responses, eventually liable to protect them against viral infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibody Formation / genetics
  • Antibody Formation / immunology*
  • CD4-CD8 Ratio
  • Cell Division / physiology
  • Cytokines / biosynthesis
  • Cytokines / genetics
  • Female
  • Genotype
  • Health Personnel
  • Hepatitis B Surface Antigens / immunology
  • Hepatitis B Vaccines / immunology*
  • Humans
  • Immunity, Cellular / genetics
  • Immunity, Cellular / immunology*
  • Immunization, Secondary
  • Lymphocytes / physiology
  • Male
  • Middle Aged
  • Occupational Exposure
  • Phenotype
  • Polymorphism, Genetic
  • T-Lymphocytes / immunology
  • Th1 Cells / immunology
  • Th1 Cells / metabolism
  • Th2 Cells / immunology
  • Th2 Cells / metabolism

Substances

  • Cytokines
  • Hepatitis B Surface Antigens
  • Hepatitis B Vaccines